Directory · US
Biotechnology in United States
A register of firms and the professionals working at them in the Biotechnology sector based in United States. Browse the public index, then filter or export on Kipplo.
Companies
2.7K on file
Bioxcel Therapeutics, Inc
Biopharmaceutical company developing transformative medicines in neuroscience utilizing artificial intelligence
51 to 200 staff
Boca Biolistics, Llc
We are a one-of-a-kind resource built for the future of life science research. BocaBio is a hybrid CRO serving the pharmaceutical, biotech, and IVD industries ISO-certified Biobanx biospecimen inventory ACRP and CCRA-certified clinical research services CLIA-certified and CAP-accredited reference laboratory services We help pharmaceutical and IVD research companies develop tomorrow’s therapies Our biobank, CRO, and reference lab services enable: Pharmaceutical companies to develop novel therapeutic drugs. IVD companies to develop innovative diagnostic technologies Biotech companies to conduct critical research.
11 to 50 staff
Cellworks
Cellworks Group, Inc. is a leader in Precision Drug Development and Personalized Therapy Biosimulation. The Cellworks Platform predicts therapy response for individual patients and patient cohorts using a breakthrough Computational Biology Model (CBM) and biosimulation technology. Backed by Artiman Ventures, Bering Capital, Sequoia Capital, UnitedHealth Group and Agilent Ventures, Cellworks has the world’s strongest trans-disciplinary team of molecular biologists, cellular pathway modelers and software technologists working toward a common goal – attacking serious diseases to improve the lives of patients.
51 to 200 staff
Central Life Sciences
Central Life Sciences is dedicated to creating healthier environments by offering trusted consumer and professionally-applied solutions to control nuisance and disease-carrying insects and support human and animal health. For more than 35 years, the professionals at Central Life Sciences, a Central Garden & Pet Company, have been dedicated to improving the health, well-being and protection of animals, plants and stored grains through a wide variety of effective products.
51 to 200 staff
Elegen
We are now at the dawn of the synthetic biology revolution, which will spawn new applications, markets, and business models, improving human lives in countless ways. This revolution will be driven by new technologies that enable DNA writing at speed and scale. To catalyze this revolution, Elegen is creating a suite of ground-breaking technologies to achieve DNA writing with unparalleled speed, cost, and quality. Elegen is unlocking the power to reprogram biology and create biologic solutions in order to solve some of humanity’s greatest challenges. Founded and led by Dr. Matthew Hill and located in San Carlos, CA, Elegen is a stealth-mode company that is well capitalized by top life science investors, including Andreessen Horowitz, 8VC, and KdT. The company is advised and staffed by leading biotechnology scientists and entrepreneurs, including Dr. Marc Unger, inventor of the Nanoflex™ valve and former CSO of Fluidigm. Dr. Hill has a PhD from Stanford and a proven track record of advancing innovative technologies from invention to commercial success.
51 to 200 staff
Greenlight Biosciences
GreenLight Biosciences is a mission-driven public-benefit corporation using the power of nature to develop and commercialize effective, easy-to-use, and environmentally friendly crop protection for farmers.
51 to 200 staff
Hamilton Company
Hamilton Company is a global enterprise with headquarters in Reno, Nevada; Franklin, Massachusetts; and Bonaduz, Switzerland and subsidiary offices throughout the world. We are an industry leader in the design and manufacture of liquid handling, process analytics, robotics and automated storage solutions. For more than 60 years, Hamilton has been meeting customer needs with a combination of quality materials and skilled workmanship that ensures the highest level of performance. Hamilton’s continued commitment to precision and quality has earned the company global ISO 9001 Certification. Founded on the technology of analytical microliter and gastight syringes, Hamilton has a broad offering of laboratory products including manual and semi-automated precision fluid measuring instruments, chromatography products, process sensors, laboratory electrodes, pipettes and more. Top innovations from these lines include Arc™ pH, DO and conductivity intelligent sensors, the BioLevitator™ 3D cell culture system, Microlab® 600 diluters/dispensers and the Microlab 300 guided pipetting system. The leader in liquid handling technology, Hamilton Robotics is recognized for advancing life science and biotechnology industries with products that offer reliability, performance and flexibility. Hamilton is the industry leader in design and manufacturing, with patented technologies such as Compression-induced O-Ring Expansion CO-RE™, Total Aspiration and Dispensing Monitoring TADM™ and Anti-Droplet Control ADC™. Hamilton’s platforms include VANTAGE Liquid Handling System™, Microlab STAR™ and Microlab NIMBUS®. Hamilton Storage offers comprehensive ultra-low temperature automated sample management systems for microtube and microplate storage. Hamilton’s line of biobanking and compound storage solutions and consumables is designed for a broad array of life science processes. Products include BiOS™, SAM™ and ASM™, designed for sample integrity, flexibility and reliability.
501 to 1000 staff
Human Longevity, Inc
Human Longevity, Inc. ™ (HLI) is the genomics-based, health intelligence company creating the world’s largest and most comprehensive database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and machine learning to make novel discoveries from these data to generate personalized health insights. Our goal is to extend healthy human life by revolutionizing human health and transforming the practice of medicine. Our DNA determines so much about each of us, but other factors can also influence our health. HLI is focused on compiling and analyzing more genotypic and phenotypic data because the combination of both enables us —to generate unprecedented insights and accelerate our understanding into what makes us who we are and what we can change for a life better lived.
51 to 200 staff
Immuneering Corporation
Immuneering is a clinical-stage oncology company focused on keeping cancer patients alive. The Company is developing an entirely new category of cancer medicines, Deep Cyclic Inhibitors. Immuneering’s lead product candidate, atebimetinib (IMM-1-104), is an oral, once-daily Deep Cyclic Inhibitor of MEK designed to improve durability and tolerability, and expand indications to include MAPK pathway-driven tumors such as most pancreatic cancers. Atebimetinib is currently in a Phase 2a trial in patients with advanced solid tumors including pancreatic cancer. The Company’s development pipeline also includes early-stage programs. For more information, please visit
11 to 50 staff
Immunomic Therapeutics, Inc
Immunomic Therapeutics, Inc.(ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform. This investigational technology has the potential to alter how we use immunotherapy for a number of diseases, including cancer, allergy and infectious diseases.
11 to 50 staff
Immy
Bringing Diagnostics closer to the patient. IMMY is a global leader in fungal and infectious disease diagnostics. Headquartered in Norman, Oklahoma since 1979, we design, manufacture, and distribute affordable and reliable diagnostic tests that bring diagnostics closer to the patient and improve clinical outcomes around the world. IMMY is committed to addressing the global challenges of delayed, inaccurate, and inaccessible fungal diagnostics by delivering innovative, high-quality solutions that ensure the right information reaches the right people at the right time. We empower healthcare providers to make informed treatment decisions that improve outcomes for patients worldwide. Through this commitment, we reduce diagnostic gaps and enhance the speed and precision of fungal disease detection, keeping the patient at the center of everything we do. With a legacy rooted in mycology and a mission to save lives, IMMY’s rapid diagnostic tools, including our flagship CrAg® LFA, help detect life-threatening infections in immunocompromised patients and elevate the standard of care in over 100 countries. Our values, compassion, innovation, simplicity, integrity, customer focus, and teamwork, drive every decision we make. Recognized as a Top Workplace and Biotech Innovator of the Year, IMMY is also one of Oklahoma’s fastest-growing life science companies. Join us in shaping the future of global health.
51 to 200 staff
Inscopix, Inc
Inscopix is pioneering a new paradigm in the quest to understand the brain and its diseases. Combining revolutionary technology and methods for the imaging of large-scale neural activity in a naturally behaving subject, Inscopix has developed the enabling means to relate causal neural circuit dynamics to corresponding behavior. With its nVista and nVoke products, Inscopix is today disseminating these capabilities to neuroscientists across the world, empowering them to gather unprecedented data and to make new scientific discoveries. With strategic collaborators and partners, Inscopix is at the same time developing in vivo neuropsychiatric disease assays and stands on the brink of making fundamental breakthroughs on treatments for brain diseases such as autism and schizophrenia. Inscopix has a rock star team, is advised by academic and industry luminaries, and is backed by leading institutional investors. To learn more about Inscopix visit: Privacy Policy: https://goto.bruker.com/LI-Bruker-PrivacyPolicy Imprint: Bruker Corporation 40 Manning Road Billerica, MA 01821, USA
51 to 200 staff
Intrexon Corporation
Through the engineering of biology, Intrexon is helping to address some of the world’s most pressing challenges and is working with industry and government leaders to realize a better, healthier planet. Today our platform is delivering new therapies in health, supplying unique solutions to address global energy demand, developing unparalleled features and productivity advancements in food, creating innovative applications for consumers, and helping to restore and protect the environment. Intrexon and our collaborators are building solutions to challenging issues across fields as diverse as medicine, fuel, agriculture, nutrition, personal care, chemicals, and manufacturing, forging a sustainable path forward for current and future generations. We call our approach Better DNA® and invite you to discover more at or follow us on Twitter at @Intrexon, on Facebook and LinkedIn.(NASDAQ:$XON)
501 to 1000 staff
Krystal Biotech, Inc
A commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines for high unmet medical needs.
201 to 500 staff
Leinco Technologies
Consultative Partner Over 30 years’ experience closely collaborating with companies to ensure high quality, reproducible products that drive scientific discovery. Custom CDMO Services From antibody scale-up and purification to advanced conjugation and assay development, our tailored services streamline your workflow and accelerate research. Wide-Ranging Applications Our products are optimized for diverse applications—including spatial biology, flow cytometry, in vivo studies, and in vitro assays—to empower researchers to uncover critical biological interactions. Advanced Production Techniques Our proprietary processes yield the purest monoclonal, recombinant, and polyclonal antibodies and proteins available, ensuring high-purity reagents that drive consistent, reproducible results. Quality & Standards Quality is non-negotiable -we strictly adhere to ISO 9001:2015 and ISO 13485:2016 standards, ensuring that every antibody and protein we produce meets rigorous performance and reliability benchmarks.
51 to 200 staff
Maia Biotechnology, Inc
MAIA Biotechnology is a targeted therapy, immune-oncology company, focused on development and commercialization of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. A publicly traded company based in Chicago, MAIA (NYSE American: MAIA) is led by a passionate, principled and highly experienced Management Team with significant drug development experience, committed to advancing promising agents into human clinical trials. MAIA’s business strategy is designed to advance a strong value proposition for its portfolio of potentially novel compounds. MAIA controls risk and enhances its opportunity for success by diversifying and generating this portfolio of assets with a variety of compounds with novel mechanisms of action which have potential activity in multiple tumor types. MAIA’s business model involves placing drug candidates in their own dedicated, R&D focused subsidiary company, which is supported by the common infrastructure, management team, and resources of the MAIA enterprise. This model allows MAIA to provide more focused R&D support to each drug candidate, while also distributing shared central resources among subsidiary companies to maintain a lean, capital-efficient operating structure.
1 to 10 staff
Metabolon, Inc
Almost every factor that affects health – from genetics and the microbiome to disease and lifestyle – exerts its influence by altering metabolite levels in the body or other biological system. By producing the most accurate and comprehensive picture of the collection of metabolites, known as the metabolome, from a single biological sample, Metabolon can deliver an instantaneous snapshot of the entire physiology of a living being at a discreet point in time, as well as identify changes in that system brought about the impact of disease, medical intervention, diet or the environment. This deep and comprehensive view of the metabolome provides biological insights that cannot be revealed through any other research methodology, enabling life sciences researchers and drug developers to discover answers some of biology’s most difficult questions. Metabolon's unrivaled capability to look deep into the metabolome has enabled us to build the world’s largest library of compounds that currently includes 5,200+ total known molecules. Our proprietary Precision Metabolomics™ platform, combined with the world's most experienced metabolomics scientists, delivers biologic insights and identification of novel commercial opportunities for drug discovery and development, through clinical trials and life cycle management. Metabolon’s expertise is also accelerating research and product development for clients in academia, population health, consumer products, and nutrition industries. Founded in and based in Research Triangle Park, North Carolina, Metabolon has conducted more than independent and collaborative studies, resulting in publications in leading peer-reviewed journals. For more information about our technology, products and services, please visit
201 to 500 staff
Noble Life Sciences Inc
Noble Life Sciences is a contract research organization (CRO) that provides a full continuum of preclinical drug, vaccine and medical device development services, from initial product discovery to GLP-compliant studies. Our services are designed to help you advance from concept to clinic faster and more efficiently. Noble's state-of-the-art facilities are located in Sykesville, MD in the BioHealth Capital Region. We offer integrated in vitro and in vivo services, including cellular and animal disease model development and experimental design, efficacy, toxicity, biodistribution and product release studies in both small and large animals. Managed by industry experts with years of experience in animal care, Noble's vivarium services group is ready to support your in vivo R&D: we provide custom housing, husbandry, and breeding; facility and program management; and high-level implementation of preclinical drug development services. Noble also offers custom antibody production services as well as tissue and animal sourcing. With an emphasis on quality, our proof-of- concept studies, early safety assessments and other pre-IND services are sure to provide a strong scientific foundation for your preclinical decisions. Noble’s key advantages are our deep expertise and the years of experience of our scientific team, who bring their insights to optimize and expedite our customers’ preclinical studies. With our quality control and expertise in cell- & animal-based models, you can trust Noble scientists to help lead and support your development programs through each phase of the preclinical process.
11 to 50 staff
Nucleus Biologics
Nucleus Biologics is a San Diego based biotechnology company and a global provider of media and supplements for the cell and gene therapy space. Their mission is to speed the time from scientific discovery to cure by driving reproducibility through Precision Cell Culture products and tools. Nucleus Biologics delivers innovative, transparent and cGMP products and services with the goal of disrupting the market and eliminating antiquated practices and products. Ultimately, Nucleus Biologics strives to create a new paradigm that serves both scientists and clinicians, while reducing the environmental footprint of cell culture.
51 to 200 staff
Nuo Therapeutics, Inc
Nuo Therapeutics, Inc. is a biomedical company that develops and commercializes individualized wound care therapies that harness a patient’s innate regenerative ability to stimulate wound healing. The Company’s flagship product, Aurix is a biodynamic hematogel derived from the patient’s own platelets and plasma, which is used at the point-of-care to jumpstart the natural healing process in a broad range of chronic wounds, including diabetic foot ulcers, venous leg ulcers and pressure injuries.
11 to 50 staff
Nuritas
Through pioneering life science and artificial intelligence, we developed our unique Nuritas MagnifierNπΦ platform that allows us to identify, unlock, clinically test and patent peptides; turning them into powerful and precise ingredients that elevate natural efficacy. We want to empower people to live healthier lives, naturally by making our everyday products healthier, safer, greener and more efficacious. From what we eat, to what we apply to our skin. By translating nature’s wisdom into innovation, together, we can change the life of billions.
51 to 200 staff
Pillar Biosciences Incorporated
Pillar Biosciences is the leader in Decision Medicine™, which is the utilization of highly accurate and sensitive next-generation sequencing (NGS) testing technology to generate data that optimizes selection of precision therapies for cancer patients, from tumor profiling to therapy selection, and recurrence monitoring. Pillar’s NGS testing solutions are powered by its proprietary SLIMamp® and PiVAT® technologies, helping to localize the testing process, reduce diagnostic costs and improve access and efficiency of complex NGS testing for clinicians, prescribers, and patients globally. The company has more than 20 NGS testing kits available in IVD or RUO formats, with multiple panels in various stages of development. Pillar Biosciences has operations in Natick, MA.
51 to 200 staff
Procell Therapies
ProCell Therapies is a leading-edge medical device and biotech/stem cell company in the $6B burdening cosmetic, spa and dermatology space. It has invented a superior device, application method and demonstrated results in generating skin vitality and healing skin injuries. Founded by a Board Certified, Academy of Dermatology MD; top-tier academic and clinical board of advisors.
11 to 50 staff
Prometheus Laboratories Inc
At Prometheus Laboratories Inc, we enable unique health solutions with novel diagnostics. As a leader of precision healthcare in gastroenterology, we develop and bring to market diagnostic tests that help physicians provide the highest level of patient care. Our commitment to innovation positions us for future growth and lays the foundation for expansion into new areas. Every day our people and products earn the trust of patients and their families.
51 to 200 staff
